BioNTech SE Miscellaneous Other Operating Expense
BioNTech SE (BNTX) reported Miscellaneous Other Operating Expense of EUR 1.09 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:MiscellaneousOtherOperatingExpense · last filed 2026-03-10
| Period end | Miscellaneous Other Operating Expense 12 month | Miscellaneous Other Operating Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.09B EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 811.50M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 293.00M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 410.00M EUR 20-F · filed 2025-03-10 | 407.00M EUR 20-F · filed 2023-03-27 |
| 2021-12-31 | 103.40M EUR 20-F · filed 2024-03-20 | 94.40M EUR 20-F · filed 2022-03-30 |
| 2020-12-31 | 2.40M EUR 20-F · filed 2023-03-27 | 2.36M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 700.00K EUR 20-F/A · filed 2022-10-26 | 739.00K EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 720.00K EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | 288.00K EUR 20-F · filed 2020-03-31 |